ENOB | Enochian Biosciences Inc.

Index- P/E- EPS (ttm)-2.00 Insider Own58.06% Shs Outstand55.98M Perf Week-16.50%
Market Cap45.94M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float23.59M Perf Month-36.94%
Income-106.70M PEG- EPS next Q- Inst Own7.20% Short Float / Ratio6.05% / 24.42 Perf Quarter-32.05%
Sales- P/S- EPS this Y-281.10% Inst Trans-3.80% Short Interest1.43M Perf Half Y-33.76%
Book/sh1.18 P/B0.67 EPS next Y- ROA-130.70% Target Price- Perf Year-77.98%
Cash/sh0.05 P/C15.84 EPS next 5Y- ROE-154.70% 52W Range0.72 - 3.83 Perf YTD-23.48%
Dividend- P/FCF- EPS past 5Y-65.40% ROI- 52W High-79.42% Beta1.09
Dividend %- Quick Ratio0.30 Sales past 5Y- Gross Margin- 52W Low8.90% ATR0.11
Employees11 Current Ratio0.30 Sales Q/Q- Oper. Margin- RSI (14)31.40 Volatility15.19% 11.90%
OptionableYes Debt/Eq0.09 EPS Q/Q34.40% Profit Margin- Rel Volume1.34 Prev Close0.73
ShortableNo LT Debt/Eq0.00 Earnings- Payout- Avg Volume58.48K Price0.79
Recom- SMA20-21.36% SMA50-26.85% SMA200-45.79% Volume78,150 Change7.94%
Apr-03-23 09:00AM
Mar-29-23 09:00AM
Mar-13-23 08:30AM
Feb-23-23 04:04PM
Nov-30-22 05:20PM
12:01AM Loading…
Oct-26-22 12:01AM
Oct-24-22 08:11PM
Oct-21-22 05:00PM
Oct-17-22 08:30AM
Sep-01-22 08:08AM
Jul-25-22 10:15AM
Jul-01-22 08:37PM
Jun-27-22 03:00PM
04:00PM Loading…
Jun-10-22 04:00PM
Jun-09-22 05:59PM
May-31-22 08:00AM
May-25-22 04:20PM
Apr-20-22 07:00AM
Apr-07-22 06:00AM
Apr-06-22 09:07AM
Apr-05-22 06:00AM
Mar-25-22 12:07PM
Mar-15-22 07:00AM
Dec-03-21 07:00AM
Oct-18-21 07:00AM
Oct-15-21 06:00PM
Oct-12-21 06:00PM
Sep-27-21 07:00AM
10:42AM Loading…
Sep-26-21 10:42AM
Sep-13-21 07:00AM
Aug-30-21 07:00AM
Aug-23-21 10:18AM
Jul-20-21 07:00AM
Jul-12-21 08:37AM
Jun-30-21 07:00AM
Jun-21-21 05:31PM
Jun-15-21 09:05AM
Jun-14-21 03:15PM
May-12-21 04:29PM
Apr-30-21 03:42AM
Mar-24-21 06:00PM
Feb-22-21 05:15PM
Nov-01-20 09:35AM
Sep-10-20 12:50AM
Jul-27-20 08:00AM
Jun-08-20 07:30AM
May-14-20 09:50AM
May-13-20 08:00AM
Apr-23-20 07:00AM
Apr-09-20 10:00AM
Feb-24-20 07:30AM
Feb-03-20 07:30AM
Jan-06-20 07:30AM
Dec-10-19 07:00AM
Nov-25-19 07:00AM
Nov-21-19 10:30AM
Oct-31-19 04:17PM
Oct-26-19 10:18AM
Jun-03-19 07:00AM
Apr-29-19 09:19AM
Mar-07-19 12:45PM
Feb-01-19 02:31PM
Jan-16-19 04:00PM
Jan-07-19 08:30AM
Jan-04-19 08:00AM
Dec-05-18 08:30AM
Dec-03-18 08:30AM
Enochian Biosciences, Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), and cancer. The company's product pipeline includes ENOB-HV-01 for autologous HIV curative treatment; ENOB-HV-12, a therapeutic HIV vaccine; and ENOB-HB-01, a gene therapy curative treatment for HBV. It develops ENOB-DC-11, an allogeneic dendritic cell therapeutic vaccine for solid tumors; ENOB-DC-12-XX, allogeneic dendritic cell therapeutic vaccine for other solid tumors; and ENOB-HV-21 for treating HIV with allogeneic natural killer (NK) and gamma delta T-cells. Enochian Biosciences, Inc. has strategic partnerships with the University of California, Fred Hutchinson Cancer Research Center, and Caring Cross. The company was incorporated in 2017 and is headquartered in Los Angeles, California.